We recently updated our Privacy Notice and Terms of Use.
Med-IQ
On the Road to Elimination: Evaluating and Improving the Continuum of Care for Patients With HCV
E-Publication E-Publication

On the Road to Elimination: Evaluating and Improving the Continuum of Care for Patients With HCV


This activity was developed by Med-IQ in collaboration with MedStar Health Research Institute.

Med-IQ      Duke Medicine
 

Released:
12/20/17
Expires:
12/19/18

Maximum Credits:

0.75
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

E-Publication E-Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
12/20/17

Expires:
12/19/18

Maximum Credits:
0.75
E-Publication E-Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
12/20/17
Expires:
12/19/18


Maximum Credits:
0.75


Overview: Significant efforts to improve HCV testing have occurred in recent years. However, if the elimination of the virus is to be possible, then all steps along the HCV care continuum need to be improved. This online publication focuses on evidence-based strategies to eliminate HCV by increasing the number of patients with chronic HCV infection who are diagnosed, treated, and cured.

CME Information:

Faculty
Dawn Fishbein, MD, MS
Scientific Director, Viral Hepatitis Research
MedStar Health Research Institute
Recruitment Module Director
Georgetown Howard Universities Center for Clinical and Translational Science CTSA
Associate Chair for Research, Department of Medicine
MedStar Washington Hospital Center
Washington, DC

Activity Planners
Sara C. Miller, MS
Director, QI Institute, CE Strategy and Content
Med-IQ
Baltimore, MD

Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Med-IQ
Baltimore, MD

Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD

Kathryn Schaefer, MSN, RN
Manager
Lead Nurse Planner
Med-IQ
East Lansing, MI
 
Writer
Anne Jacobson, MPH, CCMEP
Cocoa Beach, FL
 
Learning Objectives
Upon completion, participants should be able to:

  • Outline key steps within the HCV care continuum
  • Integrate process changes that improve patient follow-up and maximize opportunity for cure
  • Discuss reasonable expectations related to HCV treatment results and monitoring requirements

Target Audience
This activity is intended for primary care clinicians.
 
Series Overview/Statement of Need
Global discussions and goals related to the elimination of viral hepatitis have led to the development of a viral hepatitis elimination action plan by the National Academies of Science, Engineering, and Medicine. In their first report, the National Academies determined that disease elimination, though possible, will take considerable effort and resources. A more realistic shorter-term goal is disease control, which requires a reduction in the disease incidence and better overall care to reduce the downstream patient impact. Despite significant efforts to improve the identification of hepatitis C virus infection in recent years, evidence continues to indicate significant opportunities for better engagement of newly identified patients.
 
Collaborator Statement
This activity was developed by Med-IQ in collaboration with MedStar Health Research Institute.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Medium/Method of Participation
This CME/CE/CPE activity consists of a 0.75-credit publication. To receive credit, read the introductory CME/CE/CPE material, read the publication, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Initial Release Date: December 20, 2017
Expiration Date: December 19, 2018
Estimated Time to Complete This Activity: 45 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
 
Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
 
Dawn Fishbein, MD, MS
Contracted research: AbbVie Inc., Gilead Sciences, Inc., Merck & Co., Inc.
Ownership interest (stocks/stock options – excluding mutual funds): AbbVie Inc., Merck & Co., Inc.

The writer, peer reviewers, and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information       
For CME-related questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email info@med-iq.com.
                      
Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/
 
Google Chrome - latest version
Download: http://www.google.com/chrome
 
Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/ 
 
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
 
Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: http://www.med-iq.com/privacy-statement/.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.

Copyright
© 2017 Med-IQ, LLC

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.